Clinical Trial: Modified Transplantation Regimen and AGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06837987) titled 'Modified Transplantation Regimen and AGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation' on Feb. 16.

Brief Summary: We retrospectively evaluted the safety and efficacy of the modified transplantation conditioning and aGVHD prophylaxis in severe aplastic anemia in two clinical center.

Study Start Date: June 01, 2020

Study Type: OBSERVATIONAL

Condition: Aplastic Anaemia Transplantation Conditioning

Intervention: OTHER: Modified transplantation system

Modified transplantation conditioning include: Fludarabine 30mg/m2*6 day, Melphalan 100mg/m2*1 day, cyclophosphamide ...